chlortetracycline is a lipid of Polyketides (PK) class. Chlortetracycline is associated with abnormalities such as Granulomatous Disease, Chronic, Infection, Ischemia, Cerebral Ischemia and Cerebral Infarction. The involved functions are known as Regulation, Binding (Molecular Function), Agent, Stimulus and Process. Chlortetracycline often locates in Protoplasm, Plasma membrane, Membrane, Cytoplasm and specific granule. The associated genes with chlortetracycline are FPR1 gene, P4HTM gene, Homologous Gene, HIST1H1C gene and Microbiome. The related lipids are Lysophosphatidylcholines, Sterols, dilauroyl lecithin, seminolipid and Total cholesterol. The related experimental models are Mouse Model.
To understand associated biological information of chlortetracycline, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
chlortetracycline is suspected in Ischemia, Cerebral Ischemia, Cerebral Infarction, Granulomatous Disease, Chronic, Infection, Antibiotic resistant infection and other diseases in descending order of the highest number of associated sentences.
Disease | Cross reference | Weighted score | Related literature |
---|
We collected disease MeSH terms mapped to the references associated with chlortetracycline
There are no associated biomedical information in the current reference collection.
Associated locations are in red color. Not associated locations are in black.
Location | Cross reference | Weighted score | Related literatures |
---|
Function | Cross reference | Weighted score | Related literatures |
---|
Lipid concept | Cross reference | Weighted score | Related literatures |
---|
Gene | Cross reference | Weighted score | Related literatures |
---|
Mouse Model are used in the study 'Chlortetracycline and demeclocycline inhibit calpains and protect mouse neurons against glutamate toxicity and cerebral ischemia.' (Jiang SX et al., 2005).
Model | Cross reference | Weighted score | Related literatures |
---|
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
WOMACK CR and KASS EH | A substance in egg yolk which inhibits deterioration of aureomycin activity. | 1949 | Proc. Soc. Exp. Biol. Med. | pmid:15400842 |
RODRIQUEZ J and PLOTKE F | Aureomycin and its effect in early stages of syphilis; a preliminary report. | 1949 | J Am Med Assoc | pmid:15401683 |
ALMKLOV JR and HANSEN AE | Aureomycin in staphylococcic meningitis complicating subarachnoid hemorrhage in sickle cell anemia. | 1949 | Pediatrics | pmid:18131828 |
COLLINS HS and FINLAND M | Aureomycin treatment of urinary tract infections. | 1949 | Surg Gynecol Obstet | pmid:18131957 |
CUTHBERT RB | Aureomycin in the treatment of virus pneumonia. | 1949 | N Y State J Med | pmid:15407343 |
SCARZELLA M et al. | [Select cases of typhus treated with aureomycin and chloromycetin]. | 1949 | Minerva Pediatr. | pmid:15408405 |
WILLCOX RR | Aureomycin; a new treatment for syphilis? | 1949 | Br Med J | pmid:15395481 |
HARRIS WH | Aureomycin; a survey of current literature. | 1949 | Bull McGuire Clin St Lukes Hosp | pmid:15395493 |
SPINK WW and YOW EM | Aureomycin; present status in the treatment of human infections. | 1949 | J Am Med Assoc | pmid:15395553 |
CORDIER J | [Not Available]. | 1949 | J Med Chir Prat | pmid:15395584 |
FINLAND M et al. | Aureomycin in the treatment of primary atypical pneumonia. | 1949 | N. Engl. J. Med. | pmid:18109605 |
STEENKEN W and WOLINSKY E | Tuberculostatic activity of aureomycin in vitro and in vivo. | 1949 | Am Rev Tuberc | pmid:18110359 |
LONG PH | The present status of polymyxin, chloromycetin and aureomycin. | 1949 | Am Prof Pharm | pmid:18111442 |
KNIGHT V and RUIZ-SANCHES F | Aureomycin in typhus and brucellosis. | 1949 | Am. J. Med. | pmid:18115162 |
KNEELAND Y et al. | Aureomycin in the treatment of primary atypical pneumonia. | 1949 | Am. J. Med. | pmid:18110721 |
DE WIT JC | [Not Available]. | 1949 | Geneeskd Gids | pmid:18143537 |
MEIKLEJOHN G and SHRAGG RI | Aureomycin in primary atypical pneumonia; a controlled evaluation. | 1949 | J Am Med Assoc | pmid:18143684 |
KALZ F et al. | Aureomycin film in topical treatment of cutaneous virus eruptions. | 1949 | Can Med Assoc J | pmid:18136112 |
McVAY LV et al. | Septicemia due to bacteroides; aureomycin hydrochloride therapy in two cases due to Bacteroides funduliformis. | 1949 | J Am Med Assoc | pmid:18136177 |
O'LEARY PA | Treatment of syphilis by oral use of aureomycin. | 1949 | J Okla State Med Assoc | pmid:18136251 |